Daratumumab for Refractory and Frequently Relapsing Immune Thrombotic Thrombocytopenic Purpura- a Case Series with Long-Term Follow-up

被引：0
|
作者：
Schimmer, Roman R. [1 ,2 ]
van den Berg, Jana [3 ]
Schraner, Marissa [4 ,5 ]
Trinchero, Alice [1 ,2 ]
Holbro, Andreas [3 ]
Hovinga, Johanna A. Kremer [6 ,7 ]
Studt, Jan-Dirk [1 ,2 ]
机构：
[1] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
[2] Univ Zurich, Zurich, Switzerland
[3] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[4] Univ Hosp Bern, Dept Hematol, Cent Hematol Lab, Bern, Switzerland
[5] Univ Bern, Bern, Switzerland
[6] Univ Bern, Bern Univ Hosp, Dept Hematol, Bern, Switzerland
[7] Univ Bern, Bern Univ Hosp, Cent Hematol Lab, Inselspital Bern, Bern, Switzerland
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-208584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4003 / 4004
页数：2
相关论文
共 50 条
  • [1] Daratumumab for frequently relapsing and refractory immune thrombotic thrombocytopenic purpura
    van den Berg, J.
    Hovinga, J. A. Kremer
    Holbro, A.
    Studt, J. -D.
    SWISS MEDICAL WEEKLY, 2021, 151 : 18 - 18
  • [2] Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
    Garcia-Chavez, Jaime
    Majluf-Cruz, Abraham
    Montiel-Cervantes, Laura
    Esparza, Miriam Garcia-Ruiz
    Vela-Ojeda, Jorge
    ANNALS OF HEMATOLOGY, 2007, 86 (12) : 871 - 877
  • [3] Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
    Jens Marcus Chemnitz
    Jens Uener
    Michael Hallek
    Christof Scheid
    Annals of Hematology, 2010, 89 : 1029 - 1033
  • [4] Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
    Chemnitz, Jens Marcus
    Uener, Jens
    Hallek, Michael
    Scheid, Christof
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 1029 - 1033
  • [5] Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
    Jaime Garcia-Chavez
    Abraham Majluf-Cruz
    Laura Montiel-Cervantes
    Miriam García-Ruiz Esparza
    Jorge Vela-Ojeda
    Annals of Hematology, 2007, 86 : 871 - 877
  • [6] A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?
    Bonifacio, Maria Addolorata
    Roselli, Daniele
    Schifone, Claudia Pia
    Ricco, Alessandra
    Vitucci, Angelantonio
    Aprile, Lara
    Mariggio, Maria Addolorata
    Ranieri, Prudenza
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [7] Increased morbidity during long-term follow-up of survivors of thrombotic thrombocytopenic purpura
    Chaturvedi, Shruti
    Abbas, Hashim
    McCrae, Keith R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : E208 - E208
  • [8] LONG-TERM FOLLOW-UP OF TWO CHILDREN WITH RECURRENT IMMUNE THROMBOCYTOPENIC PURPURA
    Kaya, Z.
    THROMBOSIS RESEARCH, 2016, 141 : S78 - S79
  • [9] Rituximab Provided Long-Term Remission in a Patient with Refractory Relapsing Thrombotic Thrombocytopenic Purpura
    Satoru Kosugi
    Masanori Matsumoto
    Yasushi Ohtani
    Hironori Take
    Hiromichi Ishizashi
    Yoshihiro Fujimura
    Jun Kuyama
    International Journal of Hematology, 2005, 81 : 433 - 436
  • [10] Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura
    Aggarwal, Asha
    White, Danielle
    Pavord, Sue
    Thomas, Will
    Desborough, Michael J. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 429 - 433
12345